SeaCrest Wealth Management’s Alimera Sciences ALIM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-667
Closed -$6K 590
2019
Q3
$6K Hold
667
﹤0.01% 543
2019
Q2
$9K Hold
667
﹤0.01% 514
2019
Q1
$11K Hold
667
﹤0.01% 1511
2018
Q4
$7K Hold
667
﹤0.01% 1617
2018
Q3
$10K Hold
667
﹤0.01% 1665
2018
Q2
$10K Hold
667
﹤0.01% 1627
2018
Q1
$10K Sell
667
-133
-17% -$2.36K ﹤0.01% 1598
2017
Q4
$16K Buy
+800
New +$15.6K ﹤0.01% 1422

Other funds holding ALIM

SeaCrest Wealth Management's ALIM Position: Q4 2019 in Review

SeaCrest Wealth Management sold out of Alimera Sciences (ALIM) in Q4 2019, closing a stake of 667 shares — an estimated $6K sold.

SeaCrest Wealth Management first reported a position in ALIM in Q4 2017 and held it in 8 quarters. The position peaked at $16K in Q4 2017. 22 funds tracked by Wall St. Rank hold ALIM as of Q4 2019.

  • SeaCrest Wealth Management reported no remaining Alimera Sciences position as of Q4 2019 after selling out during the quarter.
  • SeaCrest Wealth Management sold 667 Alimera Sciences shares in Q4 2019, an estimated $6K.
  • SeaCrest Wealth Management first reported a position in Alimera Sciences in Q4 2017 and held it in 8 quarters.
  • SeaCrest Wealth Management's Alimera Sciences position peaked at $16K in Q4 2017.
  • 22 funds tracked by Wall St. Rank held Alimera Sciences as of Q4 2019.

Based on SeaCrest Wealth Management's 13F filing for Q4 2019, filed 22 Jan 2020.